[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337056-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337056-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","effects-of-phospholipase-d1-inhibitory-peptide-on-the-growth-and-metastasis-of-gastric-cancer-cells","Effects of phospholipase D1-inhibitory peptide on the growth and metastasis of gastric cancer cells","","Phospholipase D1 (PLD1) drives cancer development through effects on proliferation, survival, invasion, metastasis, angiogenesis, drug resistance, and tumor microenvironment modulation. The study evaluates PLD1 inhibition in gastric cancer cells using the novel peptide inhibitor TAT-TVTSP, engineered by fusing a PLD1-inhibitory sequence (TVTSP) with the cell-penetrating peptide TAT. TAT-TVTSP suppresses PLD1 activity and inhibits mTOR pathway signaling, induces cell-cycle arrest via p21/p27 activation, impairs migration and invasion, and reduces xenograft tumor growth without toxicity, supporting therapeutic potential for PLD1-mediated cancers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/effects-of-phospholipase-d1-inhibitory-peptide-on-the-growth-and-metastasis-of-gastric-cancer-cells/337056/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/effects-of-phospholipase-d1-inhibitory-peptide-on-the-growth-and-metastasis-of-gastric-cancer-cells/337056.png","ImageObject",300,407,{"name":42,"@type":43},"Seraphina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of inhibiting phospholipase D1 (PLD1) in this study?","Question",{"text":63,"@type":64},"PLD1 is described as contributing to cancer progression through multiple processes including proliferation, invasion, metastasis, and microenvironment modulation. The study aims to determine how PLD1 inhibition affects gastric cancer cell growth and metastatic behaviors.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is TAT-TVTSP designed and what does it do to PLD1 activity?",{"text":68,"@type":64},"TAT-TVTSP is engineered by fusing a PLD1-inhibitory peptide (TVTSP) with the cell-penetrating peptide (TAT). It effectively inhibits PLD1 activity in AGS gastric cancer cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What effects does TAT-TVTSP have on cell signaling and cell cycle regulation?",{"text":72,"@type":64},"TAT-TVTSP significantly inhibits mTOR signaling, including phosphorylation of downstream targets such as S6K1, AKT (S473), GSK-3β, and FOXO1. It does not induce cell death but triggers cell cycle arrest by activating p21 and p27 via AKT phosphorylation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337056,1790378778,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Molecules and Cells Research Article  \nEffects of phospholipase D1-inhibitory peptide on the growth and metastasis of gastric cancer cells  \nDongju Kim 1 , Mee-Sup Yoon2 , Junwon Lee3 , Shin-Young Park3 ,⁎, and Joong-Soo Han 1 ,4 ,⁎  \n1Department of Biomedical Sciences, Graduate School for Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea, 2Department of Molecular Medicine, College of Medicine, Gachon University, Incheon 21999, Republic of Korea, 3Department of Biotechnology, Pai Chai University, Daejeon 35345, Republic of Korea, 4Biomedical Research Institute and Department of Biochemistry & Molecular Biology, College of Medicine, Hanyang University, Seoul, Republic of Korea ⁎Correspondence: [sypark@pcu.ac.kr](sypark@pcu.ac.kr) (S.-Y. Park), [jshan@hanyang.ac.kr](jshan@hanyang.ac.kr) (J.-S. Han) .  \n[https://doi.org/10.1016/j.mocell.2024.100128](https://doi.org/10.1016/j.mocell.2024.100128)  \nABSTRACT  \nPhospholipase D1 (PLD1) contributes to cancer development and progression through its effects on cell proliferation, survival, invasion, metastasis, angiogenesis, drug resistance, and modulation of the tumor microenvironment. Its central role in these processes makes it a promising target for novel cancer treatments aimed at inhibiting its activity and disrupting the signaling pathways it regulates. In this study, we aimed to investigate the effect of PLD1 inhibition on gastric cancer cell growth using a novel peptide inhibitor, TAT-TVTSP. PLD1, which plays a role in cancer progression, catalyzes the conversion of phosphatidylcholine into choline and phosphatidic acid through hydrolysis. To effectively target PLD1 in cells, we engineered TAT-TVTSP by fusing a PLD1-inhibitory peptide (TVTSP) with a cell-penetrating peptide (TAT) . We observed that TAT-TVTSP effectively inhibited PLD1 activity in AGS gastric cancer cells. Moreover, TAT-TVTSP significantly inhibited the mammalian target of the rapamycin signaling pathway, including the phosphorylation of key downstream targets such as S6K1, AKT, S473, glycogen synthase kinase-3b, and forkhead box O1 . TAT-TVTSP did not induce cell death, but it triggered cell cycle arrest by activating p21 and p27 via AKT phosphorylation. Functional assays revealed that TATTVTSP significantly impaired the colony-forming ability of AGS cells, thus inhibiting cell proliferation. Transwell and wound-healing assays revealed that this peptide disrupted the cellular behaviors critical to cancer progression, such as migration and invasion. In vivo, TAT-TVTSP significantly reduced tumor growth in the xenograft model of gastric cancer without any toxicity. Overall, our results suggest that TAT-TVTSP is a novel therapeutic agent for PLD1-mediated cancers.  \n© 2024 The Author(s) . Published by Elsevier Inc. on behalf of Korean Society for Molecular and Cellular Biology. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/l](http://creativecommons.org/l)icenses/by-nc-nd/4 .0/) .  \nKeywords: Cell signaling cascade, Gastric cancer, Peptide inhibitor, Phospholipase D1, Mammalian target of rapamycin signaling  \nINTRODUCTION  \nGastric cancer ranks as the fifth most common cancer and is the third-highest cause of cancer-related mortality globally (Brayet al. , 2018; Li et al. , 2023) . Surgical resection is mainly used to treat gastric cancer, with radiation therapy and chemotherapy used as adjuvant and neoadjuvant therapies (Schirren et al. , 2015) . Gastric cancer is treated with various medications, such as 5-fluorouracil, cisplatin, and leucovorin, and different chemotherapy protocols. However, these regimens exert side effects and show diminished efficacy in chemotherapy-resistant patients with gastric cancer (Van Cutsem et al. , 2016) . Therefore, alternative strategies are needed to treat these patients.  \nPhospholipase D (PLD) catalyzes the conversion of phosphatidylcholine into choline and phosphatidic acid (PA) through hydrolysis (C","cbCaimw84YsXNLD3","https://ap.wps.com/l/cbCaimw84YsXNLD3","pdf",5714070,12,"English","# Abstract\n# Introduction\n## Targeting PLD1 and PLD isoforms\n## PLD1-related signaling and cancer progression\n## mTOR signaling complexes","[{\"question\":\"What is the purpose of inhibiting phospholipase D1 (PLD1) in this study?\",\"answer\":\"PLD1 is described as contributing to cancer progression through multiple processes including proliferation, invasion, metastasis, and microenvironment modulation. The study aims to determine how PLD1 inhibition affects gastric cancer cell growth and metastatic behaviors.\"},{\"question\":\"How is TAT-TVTSP designed and what does it do to PLD1 activity?\",\"answer\":\"TAT-TVTSP is engineered by fusing a PLD1-inhibitory peptide (TVTSP) with the cell-penetrating peptide (TAT). It effectively inhibits PLD1 activity in AGS gastric cancer cells.\"},{\"question\":\"What effects does TAT-TVTSP have on cell signaling and cell cycle regulation?\",\"answer\":\"TAT-TVTSP significantly inhibits mTOR signaling, including phosphorylation of downstream targets such as S6K1, AKT (S473), GSK-3β, and FOXO1. It does not induce cell death but triggers cell cycle arrest by activating p21 and p27 via AKT phosphorylation.\"}]","Effects of phospholipase D1-inhibitory peptide on the growth and metastasis of gastric cancer cells | PDF",1790017569,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7015116b61bbee5ce216e44fa91b5c66.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c43c9f7b1d63af147080a23341eb28dc.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40ba00abb0b2ef706b6d6401cbcf2eb8.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9336fb61e0b6e262fdf419383a38f01.webp",980,1306]